Related Experiment Video
Updated: Apr 20, 2026
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
1Hainan Medical University, China ; Faculty of Medicine, University of Nis, Serbia ; Joseph Ayobabalola University, Nigeria.
Background:
Down's syndrome is an important congenital chromosomal disorder that can be seen around the world. The antenatal screening for this disorder is an important processing in present obstetrics.
Objective:
Due to the concept of first do no harm, the use of noninvasive test is recommended. The triple marker screening test has been introduced for a few years and acceptable for its efficacy.
Result:
However, an important concern is on its cost-effectiveness. Here, the author analyze and present the cost-effectiveness of the triple markers serum screening for Down's syndrome in Thai setting.
Conclusion:
According to this work, the cost per effectiveness of triple markers serum screening is slightly lower than standard amniocentesis test.
